Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/10/2003US20030129742 Perfusion cultures wherein cells attach to adhesive-treated porous surface (lectins, fibronectins) and divide
07/10/2003US20030129727 Nucleic acid encoding 5'-3' exonuclease of bacteriophage RM 378
07/10/2003US20030129723 Derived from Pyrococcus; genetic engineering; improved heat resistance
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129703 Modified dorsal tissue affecting factor and compositions
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129701 Detecting a mutation in the RAR epsilon receptor nucleic acid sequences and detecting a level of the soluble form of the receptors
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129696 Polynucleotides and polypeptides encoding receptors
07/10/2003US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129689 Nucleotide sequence that encodes a PRO polypeptide.
07/10/2003US20030129688 Heregulin variants
07/10/2003US20030129687 Keratinocyte growth factor-2
07/10/2003US20030129686 Novel nucleic acid and polypeptide molecules
07/10/2003US20030129663 Methods and compositions for modulating oxidized ldl transport
07/10/2003US20030129655 Nucleic acids encoding GTPase activating proteins
07/10/2003US20030129651 Expression and purification of ATM protein using vaccinia virus
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129644 Used in gene therapy
07/10/2003US20030129628 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
07/10/2003US20030129610 New QTL's on chromosomes X, 2, 6 and 7 of pigs
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129599 Nucleotide sequence encoding a human hiwi gene; increasing retention of primitive CD34+ hematopoietic stem cells
07/10/2003US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF
07/10/2003US20030129583 Testing for the ability of a stealth virus to induce the production of auto-fluorescent material in cells; destroying suspected stealth virus infected cells in a blood sample
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer
07/10/2003US20030129206 Medicament for the immunotherapy of malignant tumours
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129200 Inoculation using polymerases that have been deactivated using ultraviolet radiation or enzyme inhibitors such as azido dipyrodiazepinona and/or N-(4-chloro-3-(3-methyl-2-butenyloxy) phenyl)-2-methyl-3-furanocarbothiamide
07/10/2003US20030129197 Influenza vaccine
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129186 Compositions and methods for modulating blood-brain barrier transport
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129176 Atherosclerosis-associated genes
07/10/2003US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents
07/10/2003US20030129174 Antihemophilic factor; insertion of culture product into blood; polypeptide
07/10/2003US20030129173 Viability and function of pancreatic islets
07/10/2003US20030129171 Cloning mastitis gene; muscular disorders
07/10/2003US20030129170 Central nervous system disorders; antidiabetic agents
07/10/2003US20030129168 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
07/10/2003US20030129166 Human circulating dendritic cell compositions and methods
07/10/2003US20030129091 Medical diagnosis; reducing stresses on sperm; artificial insemination
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471131A1 An avian embryo particulate biomass for the production of virus antigens
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471042A1 Expression vectors and promoters for heterologous gene expression
07/10/2003CA2471035A1 Knockout swine and methods for making the same
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470707A1 Cellular compositions and methods of making and using them
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325960A2 Negative strand RNA virus vector having autonomously replicating activity
07/09/2003EP1325956A1 Plant lesion formation suppressing gene, sp17 and use theriof
07/09/2003EP1325954A1 An inhibitor of arthropod chitin synthase
07/09/2003EP1325953A1 Method of culturing mesenchymal stem cells
07/09/2003EP1325932A2 Anti-vegf antibodies
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/09/2003EP1325338A2 Diagnosis and treatment of alzheimer's disease
07/09/2003EP1325142A2 Virus-based amplification vectors for plants
07/09/2003EP1325137A2 Truncated phosphodiesterase-7 polypeptides
07/09/2003EP1325136A1 Herbicide resistant plants
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325130A2 Nogo receptor homologs
07/09/2003EP1325129A2 Identification of a new cytotoxic activity from the ink of aplysia punctata
07/09/2003EP1325128A2 Lipocalins
07/09/2003EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors
07/09/2003EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof
07/09/2003EP1325121A2 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325115A2 Cytokine receptor zcytor17
07/09/2003EP1325112A2 Methods of isolating bipotent hepatic progenitor cells
07/09/2003EP1325111A1 Processes for clonal growth of hepatic progenitor cells
07/09/2003EP1325110A1 Automated bioculture and bioculture experiments system
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures
07/09/2003EP1324670A2 Growing marine fish in freshwater
07/09/2003EP1112081A4 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
07/09/2003EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
07/09/2003EP0880693B1 Use of multiple gradients in electrophoresis in gel slabs and in capillaries
07/09/2003EP0626012B1 Homogenotization of gene-targeting events
07/09/2003EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
07/09/2003CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors
07/09/2003CN1429270A Synthetic gagpol genes and their use
07/09/2003CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants
1 ... 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 ... 1827